CDMOs

Catalent buys partially built biologics plant with plans to shell out $160M to finish it
Fierce Pharma
Thu, 04/7/22 - 10:32 am
CDMOs
Catalent
biologics
drug manufacturing
Q&A: In an often-overlooked part of the state, a small Massachusetts CMO has its first FDA approval
Endpoints
Thu, 03/24/22 - 08:31 pm
CDMOs
Berkshire Sterile Manufacturing
Recipharm grows biologics business as it acquires Arranta Bio and Vibalogics
Biopharma Reporter
Fri, 02/18/22 - 10:28 am
Recipharm
biologics
M&A
CDMOs
Arranta Bio
Vibalogics
Biologics CDMO market is expanding rapidly but is challenged by capacity constraints
Biopharma Reporter
Tue, 02/15/22 - 11:26 pm
biologics
CDMOs
North American CDMO market poised for a boom to $8.65B by 2026 — report
Endpoints
Mon, 02/14/22 - 11:37 pm
CDMOs
Merck restructures to strengthen CDMO business
Biopharma Reporter
Mon, 02/14/22 - 11:07 am
Merck KGaA
restructuring
CDMOs
Merck KGaA shuffles organization to boost its CDMO operation as a top exec retires
Endpoints
Mon, 02/7/22 - 11:22 pm
Merck KGaA
CDMOs
supply chain
Fujifilm Diosynth adds on at its NC hub, bolstering lab space with plans to bring on 145 new jobs
Endpoints
Fri, 01/7/22 - 10:30 am
Fujifilm Diosynth Biotechnologies
North Carolina
CDMOs
expansions
Novo Holdings picks up injectables CDMO in push for single-use manufacturing tech
Endpoints
Thu, 01/6/22 - 11:55 pm
Novo Holdings
CDMOs
M&A
Ritedose
FUJIFILM Diosynth Biotechnologies Invests £400M in UK Bio-Mfg. Site
Contract Pharma
Thu, 12/2/21 - 12:19 pm
Fujifilm Diosynth Biotechnologies
CDMOs
UK
drug manufacturing
GenScript embraces automation at its first cell, gene therapy manufacturing US site
Fierce Pharma
Tue, 11/2/21 - 11:53 pm
GenScript
gene therapy
CDMOs
drug manufacturing
Fujifilm Diosynth Begins Building $2 Billion Cell Culture Facility in NC
BioSpace
Sat, 10/16/21 - 11:29 pm
Fujifilm Diosynth Biotechnologies
North Carolina
CDMOs
A California biotech steps into the viral vector space with new site build of $75M
Endpoints
Thu, 10/14/21 - 10:58 am
Avid Bioservices
cell therapy
gene therapy
California
CDMOs
Charles River Laboratories has been on an acquisition spree. But Tuesday, it offloaded two assets
Endpoints
Wed, 10/13/21 - 10:53 am
Charles River Laboratories
M&A
gene therapy
CDMOs
Samsung Biologics to help Enzolytics advance clinical development of mAbs
Biopharma Reporter
Mon, 10/11/21 - 10:13 am
Samsung BioLogics
Enzolytics
CDMOs
monoclonal antibodies
Medical Device Manufacturers Hit Major Hurdles—Can Contract Manufacturers Help?
Medical Devices and Diagnostics Industry
Tue, 09/28/21 - 12:17 pm
devices
Medtech
innovation
CDMOs
pandemic
supply chain
Allarity Therapeutics and Lonza to Develop and Manufacture Dovitinib
Contract Pharma
Thu, 09/23/21 - 10:37 pm
Allarity Therapeutics
Lonza
dovitinib
CDMOs
In $1B buyout, Catalent takes on gummy company to jump into a booming market
Endpoints
Mon, 08/30/21 - 11:01 am
Catalent
CDMOs
Bettera
M&A
Samsung plots $205B investment, massive hiring spree to ramp up CDMO, biosimilars and more
Fierce Pharma
Tue, 08/24/21 - 11:07 am
Samsung BioLogics
CDMOs
hirings
drug manufacturing
M&A activity vigorous in CDMO arena: CPhI
Biopharma Reporter
Wed, 08/4/21 - 10:59 am
M&A
CDMOs
CPhI

Pages